{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:02:21Z","timestamp":1789606941091,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":119,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100001513","name":"Breast Cancer Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012639","name":"METAvivor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012639","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10252-6","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:15:35Z","timestamp":1779329735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RET signaling as a mediator of estrogen receptor positive breast cancer brain metastasis"],"prefix":"10.1038","volume":"9","author":[{"given":"Simeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2392-8445","authenticated-orcid":false,"given":"Geoffrey","family":"Pecar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdalla","family":"Wedn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-6092","authenticated-orcid":false,"given":"Jagmohan","family":"Hooda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2537-6923","authenticated-orcid":false,"given":"Steffi","family":"Oesterreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9917-514X","authenticated-orcid":false,"given":"Adrian V.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"10252_CR1","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/neuonc\/noaa285","volume":"23","author":"M Kuksis","year":"2021","unstructured":"Kuksis, M. et al. The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis. Neuro Oncol. 23, 894\u2013904 (2021).","journal-title":"Neuro Oncol."},{"key":"10252_CR2","doi-asserted-by":"publisher","first-page":"5763810","DOI":"10.1155\/2022\/5763810","volume":"2022","author":"M Simsek","year":"2022","unstructured":"Simsek, M. et al. Breast cancer patients with brain metastases: a cross-sectional study. Breast J. 2022, 5763810 (2022).","journal-title":"Breast J."},{"key":"10252_CR3","doi-asserted-by":"publisher","first-page":"CT074","DOI":"10.1158\/1538-7445.AM2024-CT074","volume":"84","author":"E Hamilton","year":"2024","unstructured":"Hamilton, E. et al. Abstract CT074: ELECTRA: an open-label, multicenter, phase 1b\/2 study of elacestrant in combination with abemaciclib in patients with brain metastasis from estrogen receptor-positive (ER+), HER2-negative (HER2-) breast cancer (BC). Cancer Res. 84, CT074\u2013CT074 (2024).","journal-title":"Cancer Res."},{"key":"10252_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/jnci\/djy110","volume":"111","author":"D Vareslija","year":"2019","unstructured":"Vareslija, D. et al. Transcriptome characterization of matched primary breast and brain metastatic tumors to detect novel actionable targets. J. Natl. Cancer Inst. 111, 388\u2013398 (2019).","journal-title":"J. Natl. Cancer Inst."},{"key":"10252_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.nbd.2016.01.021","volume":"97","author":"CF Ibanez","year":"2017","unstructured":"Ibanez, C. F. & Andressoo, J. O. Biology of GDNF and its receptors\u2014relevance for disorders of the central nervous system. Neurobiol. Dis. 97, 80\u201389 (2017).","journal-title":"Neurobiol. Dis."},{"key":"10252_CR6","doi-asserted-by":"crossref","unstructured":"Jagust, P. et al. RET overexpression leads to increased brain metastatic competency in luminal breast cancer. J. Natl. Cancer Inst. 116, 1632\u20131644 (2024).","DOI":"10.1093\/jnci\/djae091"},{"key":"10252_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrc3680","volume":"14","author":"LM Mulligan","year":"2014","unstructured":"Mulligan, L. M. RET revisited: expanding the oncogenic portfolio. Nat. Rev. Cancer 14, 173\u2013186 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"10252_CR8","doi-asserted-by":"crossref","unstructured":"Vallone, S. A. et al. Aberrant RET expression affects normal mammary gland post-lactation transition, enhancing cancer potential. Dis. Model Mech. 15, dmm049286 (2022).","DOI":"10.1242\/dmm.049286"},{"key":"10252_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrendo.2016.11","volume":"12","author":"C Romei","year":"2016","unstructured":"Romei, C., Ciampi, R. & Elisei, R. A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. Nat. Rev. Endocrinol. 12, 192\u2013202 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"10252_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jtho.2017.10.021","volume":"13","author":"R Ferrara","year":"2018","unstructured":"Ferrara, R. et al. Clinical and translational implications of RET rearrangements in non-small cell lung cancer. J. Thorac. Oncol. 13, 27\u201345 (2018).","journal-title":"J. Thorac. Oncol."},{"key":"10252_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07341-4","volume":"9","author":"BS Paratala","year":"2018","unstructured":"Paratala, B. S. et al. RET rearrangements are actionable alterations in breast cancer. Nat. Commun. 9, 4821 (2018).","journal-title":"Nat. Commun."},{"key":"10252_CR12","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3389\/fphys.2018.01873","volume":"9","author":"LM Mulligan","year":"2018","unstructured":"Mulligan, L. M. GDNF and the RET receptor in cancer: new insights and therapeutic potential. Front Physiol. 9, 1873 (2018).","journal-title":"Front Physiol."},{"key":"10252_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.molmed.2010.12.007","volume":"17","author":"A Morandi","year":"2011","unstructured":"Morandi, A., Plaza-Menacho, I. & Isacke, C. M. RET in breast cancer: functional and therapeutic implications. Trends Mol. Med. 17, 149\u2013157 (2011).","journal-title":"Trends Mol. Med."},{"key":"10252_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/emmm.201302625","volume":"5","author":"A Gattelli","year":"2013","unstructured":"Gattelli, A. et al. Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells. EMBO Mol. Med. 5, 1335\u20131350 (2013).","journal-title":"EMBO Mol. Med."},{"key":"10252_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01622-7","volume":"25","author":"G Pecar","year":"2023","unstructured":"Pecar, G. et al. RET signaling in breast cancer therapeutic resistance and metastasis. Breast Cancer Res. 25, 26 (2023).","journal-title":"Breast Cancer Res."},{"key":"10252_CR16","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1158\/0008-5472.CAN-07-5100","volume":"68","author":"A Boulay","year":"2008","unstructured":"Boulay, A. et al. The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer. Cancer Res. 68, 3743\u20133751 (2008).","journal-title":"Cancer Res."},{"key":"10252_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-011-1775-9","volume":"133","author":"C Wang","year":"2012","unstructured":"Wang, C. et al. The rearranged during transfection\/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells. Breast Cancer Res. Treat. 133, 487\u2013500 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"10252_CR18","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1038\/onc.2010.209","volume":"29","author":"I Plaza-Menacho","year":"2010","unstructured":"Plaza-Menacho, I. et al. Targeting the receptor tyrosine kinase RET sensitizes breast cancer cells to tamoxifen treatment and reveals a role for RET in endocrine resistance. Oncogene 29, 4648\u20134657 (2010).","journal-title":"Oncogene"},{"key":"10252_CR19","first-page":"7284","volume":"62","author":"F Carlomagno","year":"2002","unstructured":"Carlomagno, F. et al. ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases. Cancer Res. 62, 7284\u20137290 (2002).","journal-title":"Cancer Res."},{"key":"10252_CR20","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1158\/1535-7163.MCT-11-0264","volume":"10","author":"FM Yakes","year":"2011","unstructured":"Yakes, F. M. et al. Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth. Mol. Cancer Ther. 10, 2298\u20132308 (2011).","journal-title":"Mol. Cancer Ther."},{"key":"10252_CR21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1158\/2159-8290.CD-18-0338","volume":"8","author":"V Subbiah","year":"2018","unstructured":"Subbiah, V. et al. Precision targeted therapy with BLU-667 for RET-driven cancers. Cancer Discov. 8, 836\u2013849 (2018).","journal-title":"Cancer Discov."},{"key":"10252_CR22","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1093\/annonc\/mdy137","volume":"29","author":"V Subbiah","year":"2018","unstructured":"Subbiah, V. et al. Selective RET kinase inhibition for patients with RET-altered cancers. Ann. Oncol. 29, 1869\u20131876 (2018).","journal-title":"Ann. Oncol."},{"key":"10252_CR23","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1200\/JCO.19.02551","volume":"38","author":"V Subbiah","year":"2020","unstructured":"Subbiah, V. et al. State-of-the-art strategies for targeting RET-dependent cancers. J. Clin. Oncol. 38, 1209\u20131221 (2020).","journal-title":"J. Clin. Oncol."},{"key":"10252_CR24","first-page":"27","volume":"10","author":"G Bronte","year":"2019","unstructured":"Bronte, G. et al. Targeting RET-rearranged non-small-cell lung cancer: future prospects. Lung Cancer 10, 27\u201336 (2019).","journal-title":"Lung Cancer"},{"key":"10252_CR25","doi-asserted-by":"crossref","unstructured":"Evans, E. et al. P2.03-44 BLU-667 demonstrates robust activity in RET fusion-driven intracranial tumor models. J. Thoracic Oncol. 14, S701 (2019).","DOI":"10.1016\/j.jtho.2019.08.1491"},{"key":"10252_CR26","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1158\/0008-5472.CAN-12-4265","volume":"73","author":"A Morandi","year":"2013","unstructured":"Morandi, A. et al. GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors. Cancer Res. 73, 3783\u20133795 (2013).","journal-title":"Cancer Res."},{"key":"10252_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s43018-022-00491-x","volume":"4","author":"S Garcia-Recio","year":"2023","unstructured":"Garcia-Recio, S. et al. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nat. Cancer 4, 128\u2013147 (2023).","journal-title":"Nat. Cancer"},{"key":"10252_CR28","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0092-8674(03)00435-5","volume":"113","author":"G Paratcha","year":"2003","unstructured":"Paratcha, G., Ledda, F. & Ibanez, C. F. The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 113, 867\u2013879 (2003).","journal-title":"Cell"},{"key":"10252_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1083\/jcb.201009136","volume":"192","author":"MM Bespalov","year":"2011","unstructured":"Bespalov, M. M. et al. Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin. J. Cell Biol. 192, 153\u2013169 (2011).","journal-title":"J. Cell Biol."},{"key":"10252_CR30","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0955-0674(98)80144-0","volume":"10","author":"A Howe","year":"1998","unstructured":"Howe, A. et al. Integrin signaling and cell growth control. Curr. Opin. Cell Biol. 10, 220\u2013231 (1998).","journal-title":"Curr. Opin. Cell Biol."},{"key":"10252_CR31","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie, H., Gagnon, J. & Therrien, M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat. Rev. Mol. Cell Biol. 21, 607\u2013632 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10252_CR32","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1073\/pnas.1505979112","volume":"112","author":"A Rotem","year":"2015","unstructured":"Rotem, A. et al. Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation. Proc. Natl. Acad. Sci. USA 112, 5708\u20135713 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10252_CR33","doi-asserted-by":"publisher","first-page":"a002899","DOI":"10.1101\/cshperspect.a002899","volume":"1","author":"W Meng","year":"2009","unstructured":"Meng, W. & Takeichi, M. Adherens junction: molecular architecture and regulation. Cold Spring Harb. Perspect. Biol. 1, a002899 (2009).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10252_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fonc.2018.00347","volume":"8","author":"HF Bahmad","year":"2018","unstructured":"Bahmad, H. F. et al. Sphere-formation assay: three-dimensional in vitro culturing of prostate cancer stem\/progenitor sphere-forming cells. Front Oncol. 8, 347 (2018).","journal-title":"Front Oncol."},{"key":"10252_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0042-6822(64)90301-0","volume":"23","author":"I Macpherson","year":"1964","unstructured":"Macpherson, I. & Montagnier, L. Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology 23, 291\u2013294 (1964).","journal-title":"Virology"},{"key":"10252_CR36","doi-asserted-by":"crossref","unstructured":"Borowicz, S. et al. The soft agar colony formation assay. J. Vis. Exp. 92, e51998 (2014).","DOI":"10.3791\/51998-v"},{"key":"10252_CR37","doi-asserted-by":"publisher","first-page":"24902","DOI":"10.18632\/oncotarget.15302","volume":"8","author":"Y Xiong","year":"2017","unstructured":"Xiong, Y. et al. Precursor N-cadherin mediates glial cell line-derived neurotrophic factor-promoted human malignant glioma. Oncotarget 8, 24902\u201324914 (2017).","journal-title":"Oncotarget"},{"key":"10252_CR38","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1158\/0008-5472.CAN-18-1416","volume":"78","author":"N Tasdemir","year":"2018","unstructured":"Tasdemir, N. et al. Comprehensive phenotypic characterization of human invasive lobular carcinoma cell lines in 2D and 3D cultures. Cancer Res. 78, 6209\u20136222 (2018).","journal-title":"Cancer Res."},{"key":"10252_CR39","doi-asserted-by":"crossref","unstructured":"Chuang, H. N. et al. Coculture system with an organotypic brain slice and 3D spheroid of carcinoma cells. J. Vis. Exp. 80, 50881 (2013).","DOI":"10.3791\/50881-v"},{"key":"10252_CR40","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41556-019-0404-4","volume":"21","author":"G Rodrigues","year":"2019","unstructured":"Rodrigues, G. et al. Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis. Nat. Cell Biol. 21, 1403\u20131412 (2019).","journal-title":"Nat. Cell Biol."},{"key":"10252_CR41","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"10252_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.21037\/atm.2018.04.35","volume":"6","author":"EM Brosnan","year":"2018","unstructured":"Brosnan, E. M. & Anders, C. K. Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies. Ann. Transl. Med. 6, 163 (2018).","journal-title":"Ann. Transl. Med."},{"key":"10252_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11060-016-2075-3","volume":"127","author":"R Rostami","year":"2016","unstructured":"Rostami, R. et al. Brain metastasis in breast cancer: a comprehensive literature review. J. Neurooncol. 127, 407\u2013414 (2016).","journal-title":"J. Neurooncol."},{"key":"10252_CR44","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/neuonc\/noy044","volume":"20","author":"R Pedrosa","year":"2018","unstructured":"Pedrosa, R. et al. Breast cancer brain metastasis: molecular mechanisms and directions for treatment. Neuro Oncol. 20, 1439\u20131449 (2018).","journal-title":"Neuro Oncol."},{"key":"10252_CR45","doi-asserted-by":"crossref","unstructured":"Zimmer, A. S., Van Swearingen, A. E. & Anders, C. K. HER2-positive breast cancer brain metastasis: a new and exciting landscape. Cancer Rep. 5, e1274 (2020).","DOI":"10.1002\/cnr2.1274"},{"key":"10252_CR46","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41416-020-01175-y","volume":"124","author":"C Bailleux","year":"2021","unstructured":"Bailleux, C., Eberst, L. & Bachelot, T. Treatment strategies for breast cancer brain metastases. Br. J. Cancer 124, 142\u2013155 (2021).","journal-title":"Br. J. Cancer"},{"key":"10252_CR47","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/s41591-022-01935-8","volume":"28","author":"R Bartsch","year":"2022","unstructured":"Bartsch, R. et al. Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial. Nat. Med. 28, 1840\u20131847 (2022).","journal-title":"Nat. Med."},{"key":"10252_CR48","first-page":"1286","volume":"11","author":"XY Meng","year":"2021","unstructured":"Meng, X. Y. et al. Pinin promotes tumor progression via activating CREB through PI3K\/AKT and ERK\/MAPK pathway in prostate cancer. Am. J. Cancer Res. 11, 1286\u20131303 (2021).","journal-title":"Am. J. Cancer Res."},{"key":"10252_CR49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/jcp.21186","volume":"214","author":"L Caravatta","year":"2008","unstructured":"Caravatta, L. et al. PI3-K\/Akt-dependent activation of cAMP-response element-binding (CREB) protein in Jurkat T leukemia cells treated with TRAIL. J. Cell Physiol. 214, 192\u2013200 (2008).","journal-title":"J. Cell Physiol."},{"key":"10252_CR50","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1167\/iovs.09-3974","volume":"51","author":"N Babchia","year":"2010","unstructured":"Babchia, N. et al. The PI3K\/Akt and mTOR\/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf\/ERK. Invest Ophthalmol. Vis. Sci. 51, 421\u2013429 (2010).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10252_CR51","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5483\/BMBRep.2008.41.6.415","volume":"41","author":"PG Suh","year":"2008","unstructured":"Suh, P. G. et al. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep. 41, 415\u2013434 (2008).","journal-title":"BMB Rep."},{"key":"10252_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/1097-0142(19940101)73:1<36::AID-CNCR2820730108>3.0.CO;2-5","volume":"73","author":"DY Noh","year":"1994","unstructured":"Noh, D. Y. et al. Elevated content of phospholipase C-gamma 1 in colorectal cancer tissues. Cancer 73, 36\u201341 (1994).","journal-title":"Cancer"},{"key":"10252_CR53","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1200\/JCO.2005.04.8306","volume":"24","author":"S Kalyankrishna","year":"2006","unstructured":"Kalyankrishna, S. & Grandis, J. R. Epidermal growth factor receptor biology in head and neck cancer. J. Clin. Oncol. 24, 2666\u20132672 (2006).","journal-title":"J. Clin. Oncol."},{"key":"10252_CR54","doi-asserted-by":"publisher","first-page":"17751","DOI":"10.18632\/oncotarget.7474","volume":"7","author":"C Li","year":"2016","unstructured":"Li, C. et al. CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation. Oncotarget 7, 17751\u201317759 (2016).","journal-title":"Oncotarget"},{"key":"10252_CR55","first-page":"427","volume":"78","author":"M Chayan","year":"2023","unstructured":"Chayan, M., Al-Fahad, D. & Al-Bedhawi, M. The role of Akt\/Rab5A signalling in regulating cell migration of MDA-MB-231 breast cancer cell line. Arch. Razi Inst. 78, 427\u2013434 (2023).","journal-title":"Arch. Razi Inst."},{"key":"10252_CR56","first-page":"263","volume":"44","author":"LH Tetri","year":"2020","unstructured":"Tetri, L. H. et al. RET receptor expression and interaction with TRK receptors in neuroblastomas. Oncol. Rep. 44, 263\u2013272 (2020).","journal-title":"Oncol. Rep."},{"key":"10252_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95612-4","volume":"11","author":"M Moccia","year":"2021","unstructured":"Moccia, M. et al. Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases. Sci. Rep. 11, 16103 (2021).","journal-title":"Sci. Rep."},{"key":"10252_CR58","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1158\/0008-5472.CAN-22-3484","volume":"83","author":"X Gou","year":"2023","unstructured":"Gou, X. et al. Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer. Cancer Res. 83, 3237\u20133251 (2023).","journal-title":"Cancer Res."},{"key":"10252_CR59","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1158\/1078-0432.CCR-15-1534","volume":"22","author":"P Wang","year":"2016","unstructured":"Wang, P. et al. Sensitive detection of mono- and polyclonal ESR1 mutations in primary tumors, metastatic lesions, and cell-free DNA of breast cancer patients. Clin. Cancer Res. 22, 1130\u20131137 (2016).","journal-title":"Clin. Cancer Res."},{"key":"10252_CR60","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s40425-019-0755-1","volume":"7","author":"L Zhu","year":"2019","unstructured":"Zhu, L. et al. Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors. J. Immunother. Cancer 7, 265 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"10252_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-27987-5","volume":"13","author":"N Cosgrove","year":"2022","unstructured":"Cosgrove, N. et al. Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities. Nat. Commun. 13, 514 (2022).","journal-title":"Nat. Commun."},{"key":"10252_CR62","doi-asserted-by":"crossref","unstructured":"Priedigkeit, N. et al. Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases. JCI Insight2, e95703 (2017).","DOI":"10.1172\/jci.insight.95703"},{"key":"10252_CR63","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R. et al. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"10252_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."},{"key":"10252_CR65","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346\u2013352 (2012).","journal-title":"Nature"},{"key":"10252_CR66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"10252_CR67","doi-asserted-by":"publisher","unstructured":"Shah, O. S. et al. Multi-omic characterization of ILC and ILC-like cell lines as part of ILC cell line encyclopedia (ICLE) defines new models to study potential biomarkers and explore therapeutic opportunities. Preprint at https:\/\/doi.org\/10.1101\/2023.09.26.559548 (2023).","DOI":"10.1101\/2023.09.26.559548"},{"key":"10252_CR68","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi, M. et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569, 503\u2013508 (2019).","journal-title":"Nature"},{"key":"10252_CR69","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"10252_CR70","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000055464","volume":"30","author":"N Takahashi","year":"1998","unstructured":"Takahashi, N. et al. Cell growth inhibition and DNA incorporation of mitomycin C in cell culture. Ophthalmic Res. 30, 120\u2013125 (1998).","journal-title":"Ophthalmic Res."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10252-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10252-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10252-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:02:54Z","timestamp":1789603374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10252-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10252"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10252-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1209"}}